Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Currently there are no specific vaccines or medicines that have been proven to be effective against Ebola.
The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.
- Congo rapidly curtails Ebola
Thu, 19 Jul 2018 17:52 GMT
- Congo's Ebola outbreak is all but over. Did an experimental vaccine help?
Wed, 18 Jul 2018 17:42 GMT
- Ebola Eludes Drug Testing Once More as Outbreak Tapers Off
Thu, 19 Jul 2018 13:19 GMT
- Broadly acting antibodies found in plasma of Ebola survivors
Tue, 17 Jul 2018 15:00 GMT
- NIH Research Finds Ebola Treatment in the Blood of Survivors
Wed, 18 Jul 2018 18:59 GMT
- Broadly Acting Antibodies in Blood of Ebola Survivors Offer Ample Protection Against Disease
Tue, 17 Jul 2018 20:57 GMT
- An Ebola Outbreak Has Just Been Stopped. Here's What It Tells Us About Containing Epidemics.
Fri, 13 Jul 2018 14:07 GMT
- Official End to Congo Ebola Outbreak Seen Near
Tue, 17 Jul 2018 14:18 GMT
- AHF Praises Congo Ebola Response; Calls for Wider Vaccine Distribution
Thu, 19 Jul 2018 07:56 GMT
- Antibodies In Ebola Survivors' Blood Are 'Promising Candidates' For Therapy Development, NIH-Supported Study Shows
Thu, 19 Jul 2018 16:07 GMT
- Ebola survivors suffer 'severe' neurological and psychiatric effects, new study finds
Thu, 12 Jul 2018 22:04 GMT
- 'Health workers were dying left, right and centre. It was one of the most difficult things' - Ireland's ambassador to Sierra ...
Fri, 20 Jul 2018 10:18 GMT
- Ebola survivors suffer severe mental and neurological problems
Wed, 11 Jul 2018 16:13 GMT
- Targeting semen proteins may stop Ebola spreading via sex
Wed, 11 Jul 2018 13:51 GMT
- Global Community Must Continue To Examine Lessons From Ebola Outbreak Containment, Experts Say
Mon, 16 Jul 2018 15:09 GMT
- PRO/AH/EDR> Ebola update (53): Congo DR, cases, surveillance, action
Fri, 20 Jul 2018 12:03:34 -0400
Ebola -- DR Congo
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), have discovered a new set of broadly neutralizing monoclonal antibodies (mAbs) in the blood of Ebola survivors, which proved protective against disease caused by _Zaire_, _Bundibugyo_, and _Sudan_ ebolaviruses. The findings were published today in the journal Immunity.
In the study, the researchers analyzed plasma from 17 Ebola survivors and found that 2 survivors produced antibodies that bound to an